Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynergia Energy Regulatory News (SYN)

Share Price Information for Synergia Energy (SYN)

Share Price is delayed by 15 minutes
Get Live Data
0.01    -0.0005 (-4.76%)
Bid:
0.009
Ask:
0.011
Spread: 0.002 (22.222%)
Market Cap: £1.56m
SYN Live PriceLast checked at - London Stock Exchange

Intraday Synergia Energy Share Chart

Holding(s) in Company

24 Nov 2014 11:31

RNS Number : 8148X
Plastics Capital PLC
24 November 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

PLASTICS CAPITAL PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

ü

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

HARGREAVE HALE LIMITED

4. Full name of shareholder(s)  (if different from 3.):iv

DISCRETIONARY CLIENTS

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

20 NOVEMBER 2014

6. Date on which issuer notified:

24 NOVEMBER 2014

7. Threshold(s) that is/are crossed orreached: vi, vii

5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Indirect

Direct xi

Indirect xii

Direct

Indirect

GB00B289KK20

1,357,000

1,357,000

1,795,775

1,795,775

5.0808%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

1,795,775

5.0808%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

1,343,775 of these shares are held for a unit trust operated by Marlborough Fund Managers Ltd, for whom Hargreave Hale Ltd manages the investments on a discretionary basis. The remaining shares are held for other discretionary clients.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

Result of participation in recent placing.

14. Contact name:

David Clueit

15. Contact telephone number:

01253 754739

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUSUARSKAAUAA
Date   Source Headline
27th May 20267:00 amRNSCambay PSC Update
12th May 20267:00 amRNSAppointment of Non-Executive Director
5th May 20267:00 amRNSCambay PSC and Board Changes
7th Apr 20267:00 amRNS$0.7m loan agreement
26th Mar 20267:00 amRNSInterim Report for the Half-Year Ended 31 Dec 2025
6th Mar 20261:52 pmRNSCambay PSC Production Update - Correction
6th Mar 20267:00 amRNSCambay PSC Production Update
9th Feb 20261:29 pmRNSCambay PSC Sale Agreement Update
22nd Jan 20267:00 amRNSCambay PSC Update
29th Dec 202511:22 amRNSResults of General Meeting
29th Dec 202511:22 amRNSResults of General Meeting
3rd Dec 20253:40 pmRNSCambay PSC Sale FAQs / Cambay PSC Update
1st Dec 202511:15 amRNSProposed Sale, cancellation of admission, & GM
1st Dec 202510:48 amRNSResults of Annual General Meeting
1st Dec 20257:00 amRNSCambay PSC SPA Signature / Cambay PSC Update
17th Nov 20259:30 amRNSCambay PSC Update
10th Nov 20251:00 pmRNSCambay PSC Update
4th Nov 20259:44 amRNSCambay PSC Update
3rd Nov 20257:00 amRNSAGM – Notice of Meeting
29th Oct 20257:00 amRNSCambay PSC Update
20th Oct 20257:00 amRNSCambay PSC Update
7th Oct 20257:00 amRNSAudited Annual Report for Year Ended 30 June 2025
16th Sep 20257:00 amRNSCambay PSC Update
27th Aug 20257:00 amRNSCambay PSC Update
4th Aug 20257:00 amRNSCambay PSC Update
21st Jul 202510:15 amRNSTR-1 Standard form notification of major holdings
8th Jul 20257:01 amRNSCambay PSC Work Program Update
8th Jul 20257:00 amRNSCorrection - Proposed Sale of Cambay PSC
4th Jul 202511:32 amRNSProposed Sale of Cambay PSC to Selan Exploration
24th Jun 202510:08 amRNSTR-1: Standard form notification of major holdings
10th Jun 20257:00 amRNSChange of Nominated Advisor
2nd Jun 20257:53 amRNSCambay PSC Update
4th Apr 202510:11 amRNSCambay PSC Update
14th Mar 20251:50 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSInterim Financial Report
24th Feb 20257:00 amRNS£750,000 Fundraise
10th Feb 20257:00 amRNSOperations Update
4th Feb 20257:00 amRNSAppointment of Executive Director
10th Jan 20257:00 amRNSChange of Joint Broker
19th Dec 20247:00 amRNSCambay Workover Update
5th Dec 20249:45 amRNSHolding(s) in Company
28th Nov 20244:00 pmRNSMedway Hub Camelot CCS Project Update
22nd Nov 20241:01 pmRNSResults of Annual General Meeting
20th Nov 20247:00 amRNSOption Exercise, Placing Update and TVR
8th Nov 20247:00 amRNSCambay Operational Update
5th Nov 20247:00 amRNSOperational Update, Equity Issue and TVR
30th Oct 20241:00 pmRNSIssue of Options
24th Oct 20247:00 amRNSAGM - Notice of Meeting
23rd Oct 202410:37 amRNSChange of Directors
14th Oct 20247:00 amRNSCambay Work Program Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.